ArticleFrontiers in pharmacology2024

Targeting hexokinase 2 for oral cancer therapy: structure-based design and validation of lead compounds.

Purbali Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.